Video Latest - ecancer

OCTAVIA trial: bevacizumab and paclitaxel treatment for ovarian cancer

Dr Antonio Gonzalez-Martin – MD Anderson Cancer Center, Madrid, Spain

30 Oct 2012

State of PARP inhibitors and anti-angiogenics

Prof Stan Kaye – Royal Marsden Hospital, London, UK

29 Oct 2012

Study of ovarian cancer and endometriosis sub-fertility

Prof Curt Burger – Erasmus University, Rotterdam, Netherlands

29 Oct 2012

New therapies to treat advanced endometrial cancer

Prof Gini Fleming – University of Chicago Medical Center, Illinois, USA

29 Oct 2012

Defining and advancing individualised medicine

Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA

29 Oct 2012

Effects of early ovarian cancer screening

Dr Ed Pavlik – University of Kentucky, Lexington, USA

29 Oct 2012

Sexual health during and after ovarian cancer treatment

Dr Susan Carr – Royal Women’s Hospital, Parkville, Australia

29 Oct 2012

6th International Workshop on Myeloma Pharmacogenomics and Novel Therapeutics

Prof Keith Stewart, Prof Gareth Morgan, Dr Stuart Smith

23 Oct 2012

A multi-discipline approach to personalised medicine

Prof Vincenzo Valentini – President of ESTRO; Prof Peter Naredi – ESSO, Former President; Prof Paolo Casali – ESMO, Executive Board Member

22 Oct 2012

Challenges to the development of personalised medicine

Prof Alexander Eggermont – President of the European Academy of Cancer Sciences; Prof Franҫoise Meunier – Director General, EORTC

22 Oct 2012

Development of oncology policy

Prof Jose Mariano Gago – ECCO Political Advisor

22 Oct 2012

The role of patients in personalised medicine development

Ian Banks – ECCO Patient Advisory Committee; Jan Geissler – ECCO Patient Advisory committee

22 Oct 2012

Video